Mabuterol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391725This classification denotes a beta-adrenergic agonist with the molecular formula C13H18ClF3N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R4K19W6S7Q, chemically known as benzenemethanol, 4-amino-3-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)-5-(trifluoromethyl)- but generally known as mabuterol, which bears US NIH Compound Identifier 3995. European Medicines Agency schedules Mabuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08631MIG. The term MABUTEROL is an International Non-Proprietary Name. MABUTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mabuterol under HS 29221980 and SITC 51461. As of Q4 2014, MABUTEROL remains the US FDA Preferred Term for this commodity. Mabuterol bears US NLM identifiers UMLS ID C0065464 and NCI Concept Code C81647. SMILES: CLC1CC(C(O)CNC(C)(C)C)CC(C1N)C(F)(F)F.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.